about
The hepatic apelin system: a new therapeutic target for liver diseasePlasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapyRegression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates.Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.Mir-33 regulates cell proliferation and cell cycle progression.Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis.Akt-mediated foxo1 inhibition is required for liver regeneration.Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis.Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites.The Role of Akt in Chronic Liver Disease and Liver Regeneration.Prognostic value of plasma apelin concentrations at admission in patients with ST-segment elevation acute myocardial infarction.Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis.Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells.Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells.Prognosis of new-onset heart failure outpatients and collagen biomarkers.Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes.Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver.Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosisAdmission B-type natriuretic peptide retains prognostic value in patients with acute coronary syndrome and preserved left ventricular ejection fraction.Down the liver sinusoidal endothelial cell (LSEC) hole. Is there a role for lipid rafts in LSEC fenestration?Factors involved in extracellular matrix turnover in human derived cardiomyocytes.Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats.Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submiA small population of liver endothelial cells undergoes endothelial-to-mesenchymal transition in response to chronic liver injury.Identification of the potentially arrhythmogenic substrate in the acute phase of ST-segment elevation myocardial infarction.Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice.Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping.Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections.Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats.Inactivation of extrahepatic vascular Akt improves systemic hemodynamics and sodium excretion in cirrhotic rats.Glucocorticoid alternative effects on proliferating and differentiated mammary epithelium are associated to opposite regulation of cell-cycle inhibitor expression.Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems.
P50
Q28295197-E452D7AC-09BD-473B-BDA5-B44EAC4D8952Q33803826-900C403B-171A-4595-95EC-C2788E898A97Q33920996-CB7BB78C-CC1C-4E27-B79F-F580C995CB8DQ34144300-5687B31D-B05E-45C7-A7DE-4869D01DC037Q34282455-517B1FEE-3BB5-4E54-9765-0D2CFFED00CDQ35652638-A8DD0EEC-F044-4EB0-A06C-E2CEB3F77170Q35842152-F7EB85F0-88AE-4C88-951A-8C6A24B89AFBQ35881967-99C8A588-396E-44C5-B33E-7E929F3B2B0FQ36064692-E75A6452-4A53-4E36-833C-D2BFEDF7C1EFQ37220007-2307E21A-FBEE-4AE6-BFE7-48BEFDEC4D5BQ37525730-67EC7C23-7BF8-4F4A-BB5F-9ECF5AD16F42Q38366999-D52340F3-6BBB-4041-B280-2C17E56FC851Q38743020-DE0E7CC1-E9AE-4F0A-97A4-4E50370F578FQ39136962-C2F517A2-11EF-49D2-A35C-DF5AEDA50FC3Q39151737-ECE8FB16-B73D-4889-B5DE-31D69629AAC4Q39533703-51C5DACA-385E-4F59-A496-FE79D3F931C9Q39596531-32C63B79-1B67-4057-BDB7-E3E165B8AFC8Q39732824-40AE2843-D8EA-4725-8825-1F0165BFEDEBQ39772282-D693E7CE-F80F-469B-B935-67D484F1EC50Q39911150-6A55CC40-1A47-4F5E-8629-79699736B270Q40068184-A32CF305-7420-49C4-8E7C-A6E1926A4B9FQ40801879-7C6B0411-3D94-4983-8CA9-3A26E5728699Q41666901-A4F62E3F-F7A1-401B-B6E6-05CF173EB2F9Q41786318-6E3C2014-F23B-4ED6-B0C2-F7D0B10B4557Q42443800-3B912ED0-1C9C-4C89-8343-81F17A90A154Q42792494-D6B3EC42-B690-4FD6-A11F-A853A5A22322Q43892316-99A4A0BC-9090-43F2-A085-C963E202D094Q43967166-2A127FFA-F3A6-4AEC-9CA6-5D238F0F6B4FQ44994063-A87556F0-896C-4545-B110-19FC61757CEAQ45265633-580D6AD1-FDC6-40D3-B409-8A94E73F450AQ45716509-812EE648-EC4A-4126-A909-A232C40BF4CDQ47966770-A4287F0E-F590-4F6E-AB0B-B2A7100FD0C3Q48005311-D78772C4-EAB2-485C-BD94-18A8EE519EB8Q49064298-D35AA019-6293-4C8F-A15D-D40C33F0DFD6Q50230482-633ECAD3-C1A1-4D06-867A-F563893BBFB7Q50477366-18F73C86-F221-420F-9E1B-B502E1210D29Q50506466-47F03787-60F8-43AD-855C-CE07D153688AQ50562458-CCA016E7-7816-4C9F-9833-278C76A3C5B3Q51863621-7A33462F-2E67-4FDA-B518-1BFE0A7611E5Q54543865-9BD06F4E-6E0C-4F1D-84F6-D08C9D245F9B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manuel Morales Ruiz
@es
Manuel Morales-Ruiz
@en
Manuel Morales-Ruiz
@nl
type
label
Manuel Morales Ruiz
@es
Manuel Morales-Ruiz
@en
Manuel Morales-Ruiz
@nl
altLabel
Manuel Morales-Ruiz
@es
Morales-Ruiz M
@en
prefLabel
Manuel Morales Ruiz
@es
Manuel Morales-Ruiz
@en
Manuel Morales-Ruiz
@nl
P1053
L-1031-2014
P106
P1477
Manuel Morales Ruiz
@es
P1950
P21
P31
P3829
P496
0000-0002-9074-2272